Breadcrumb links

Navigation

Use of animals in medical research

The use of animals in medical research remains essential. However, in accordance with the law, scientists must avoid using animals wherever possible. If applying for funding for studies involving animals, researchers must give sound scientific reasons for using them and explain why there are no realistic alternatives.

Around 30 per cent of the research we fund involves animals. We are committed to ensuring that these programmes follow high standards of animal welfare. This page provides information about our work and ethical policy in this area.

Review of Research Using Non-Human Primates

The Biotechnology and Biological Sciences Research Council (BBSRC), Medical Research Council (MRC) and Wellcome Trust commissioned and funded the independent Review of Research Using Non-Human Primates led by Professor Sir Patrick Bateson FRS following the recommendation of a 2006 Working Group chaired by Sir David Weatherall that they undertake a systematic review of the outcome of all their research using non-human primates supported over the last decade.

 

Promoting the 3Rs

As part of our commitment to animal welfare, the MRC plays an active role in developing and disseminating the principles of the 3Rs:

    • Replacement of animals with humane alternatives wherever possible
    • Reduction in the numbers of animals used
    • Refinement of husbandry and procedures to minimise any pain and suffering the animals may experience and to improve animal welfare.

 

We are co-funders of the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs). More information on the NC3Rs website.

 

MRC policy and publications

The MRC has issued various sets of guidance concerning the use of animals in research:

 

ARRIVE guidelines

  • Animal Research: Reporting of In Vivo Experiments: The responsibility in the use of animals in bioscience research document also encourages researchers to report animal-based studies in accordance with the ARRIVE Guidelines. These guidelines are intended to improve standards of reporting and ensure that the data from animal experiments can be fully evaluated and utilised. The guidelines have been published in the journal PLoS Biology and seven other journals. The ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines have been developed by the NC3Rs to improve standards of reporting and ensure that the data from animal experiments can be fully evaluated and utilised. The guidelines are primarily aimed at scientists writing up their research for publication or involved in peer review. Developed in consultation with the scientific community, including researchers, statisticians, journal editors, and funders, the guidelines consist of a 20-point checklist of the essential information that should be included in publications reporting animal research.

 

 

In relation to use of non-human primates, the MRC has adopted the following NC3Rs policy and guidance for research establishments:

 

MRC publications

  • Mice and Medicine: an MRC publication aimed at general audiences explaining why and how research involving animals continues to contribute to medical progress
  • Primates in Medical Research: An MRC/Wellcome Trust publication aimed at general audiences explaining when and how non-human primates are used in medical research, why it is necessary and the benefits for human health.
  • The use of non-human primates in research - The Weatherall Report: An independent study funded by the Academy of Medical Sciences, the Royal Society, the Medical Research Council and the Wellcome Trust. The group, chaired by Sir David Weatherall, concludes there is a scientific case for careful, meticulously regulated non-human primate research, provided it is the only way of solving important questions and high standards of welfare are maintained. December 2006.

 

Consultations

House of Lords’ Science and Technology Committee

The MRC submitted two sets of written evidence to the House of Lords’ Science and Technology Committee Inquiry on “Animals in Scientific Procedures”. These contain further information about the MRC’s views on the topic:

Nuffield Council on Bioethics

 

Animal Procedures Committee

 

European Food Safety Authority (EFSA)

The EFSA was invited by the European Commission to produce a scientific opinion on questions relating to the revision of Directive 86/609/EEC on the use of animals in research.

The EFSA’s Animal Health and Welfare Panel has produced an opinion which has now been endorsed by EFSA. Read the MRC’s comments on this opinion as at January 2006 (PDF 48k). In June 2006, the Commission released two consultations on its proposals for revising the Directive. The expert questionnaire set out in detail the Commission’s aims and an impact assessment for each of the 19 or so proposed changes.

 

Home Office

 

Home Office Consultation on Transposition of European directive 2010/63/EU - protection of animals used for scientific purposes

The MRC supports and signed up to the UK Bioscience Sector Coalition response to the Home Office Consultation on the Transposition of European Directive 2010/63/EU.

 

The MRC and BBSRC also submitted a joint response to this consultation; the areas we have commented on in our joint response are those where the MRC/BBSRC community have additional expertise and experience, which may be of help to the Home Office.

 

Department for Environment, Food and Rural Affairs (DEFRA)

 

CMP/RDS Review Committee

 

European Commission

 

House of Lords European Union Committee

 

Academy of Medical Sciences (AMS)

 

Contact Us
  • Comment?
  • Question?
  • Request?
  • Complaint?

Get in touch